Münire Turhan

Dr. Münire Turhan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Life
Verified
Journal Article
Open access
PDF file
Ebubekir İzolEbubekir İzol
Ebubekir İzol
MTMünire Turhan
Münire Turhan
Propolis is very significant in terms of its phytochemical content and biological activity among bee products. In this study, the antioxidant activities (total phenolic and flavonoid, Fe3+, Cu2+ (CUPRAC), Fe3+-TPTZ (FRAP) reducing, and DPPH•, ABTS•+ scavenging assays) of propolis collected from the Bitlis province of Türkiye were determined. In addition, the carbonic anhydrase I and II isoenzymes (hCA I and hCA II), α-glycosidase, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibition activity and phytochemical profile of propolis and mineral content were determined by LC-MS/MS and ICP-MS, respectively. In propolis, 31 phytochemicals were found, and the highest concentration of acacetin (23.604 mg/g) was detected. It is seen that the phytochemicals in propolis provide antioxidant properties. The mineral content was screened for 18 elements and determined to be rich in the elements that make up the salt content. Total phenolic content was 215.14 mg GAE/g, and total flavonoid content was 79.11 mg QE/g. The Fe3+ reduction result was 0.940 (µg/mL), CUPRAC 1.183 (µg/mL), FRAP 0.963 (µg/mL), DPPH• scavenging IC50: 16.7 (µg/mL), and ABTS IC50: 8.01 (µg/mL). hCA I enzyme inhibition results in IC50: 7.19 (µg/mL), hCA II 8.15, AChE 5.17, BChE 7.50, and α-Glycosidase 5.72. As a result of this study, it was determined that Bitlis propolis has high antioxidant properties and a rich phytochemical content. It was also observed that it is an effective enzyme inhibitor against epilepsy, glaucoma, Alzheimer’s, and diabetes, which are important diseases, and it can be evaluated in the treatment of these diseases and drug production.

23 September 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
MTMünire Turhan
Münire Turhan
Background/Objectives: Honey is a natural product with important nutritional and biological properties. This study aimed to comprehensively evaluate honey samples with regard to physicochemical quality, safety, antioxidant capacity, and enzyme inhibitory activities. Methods: Moisture, proline, diastase activity, electrical conductivity, free acidity, sugar composition, and hydroxymethylfurfural (HMF) were determined according to relevant Turkish Food Codex, Codex Alimentarius, and International Honey Commission criteria. Naphthalene and residues of 92 antibiotics were analyzed to assess potential contamination. Antioxidant activity and inhibitory effects against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glycosidase were also evaluated. Results: The physicochemical parameters of the honey samples were generally within the established quality limits. Naphthalene was not detected in any sample, while none of the 92 analyzed antibiotics was detected above the limit of quantification. The samples exhibited measurable antioxidant activity and inhibitory effects against AChE, BChE, and α-glycosidase, indicating the presence of bioactive constituents that may contribute to these biological effects. Conclusions: The investigated honey samples demonstrated satisfactory physicochemical quality and safety, with no detectable naphthalene or antibiotic residues. Their antioxidant and enzyme inhibitory activities further highlight honey as a promising natural source of bioactive compounds with potential functional and health-promoting properties.

29 September 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
Ebubekir İzolEbubekir İzol
Ebubekir İzol
ÜYülkü Yerebasan
ülkü Yerebasan
EKEsma Kayaoğlu
Esma Kayaoğlu
MTMünire Turhan
Münire Turhan
Mustafa Abdullah YILMAZMustafa Abdullah YILMAZ
Mustafa Abdullah YILMAZ
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin
Background/Objectives: Royal jelly is a biologically active bee product with a complex chemical composition and diverse biological properties. This study aimed to comprehensively characterize the phytochemical composition of royal jelly and evaluate its antioxidant capacity, enzyme-inhibitory abilities, and potential molecular interactions with target enzymes. Methods: The phytochemical profile of royal jelly was characterized using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Total phenolic and flavonoid contents were determined spectrophotometrically. Antioxidant activity was evaluated using DPPH•, ABTS•+, and DMPD•+ scavenging assays, together with Fe3+, CUPRAC, and FRAP reducing methods. Enzyme-inhibitory abilities were assessed against human carbonic anhydrase I and II (hCA I and hCA II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α-glucosidase, and α-amylase. Molecular docking analyses were subsequently performed to investigate the interactions of major identified compounds with enzyme active sites. Results: LC–MS/MS analysis revealed a diverse profile of phenolic and flavonoids, including quinic acid, caffeic acid, chlorogenic acid, p-coumaric acid, apigenin, luteolin, kaempferol, and amentoflavone. Royal jelly exhibited considerable antioxidant activity, with IC50 values of 29.33, 29.20, and 21.65 μg/mL in the DPPH•, ABTS•+, and DMPD•+ scavenging assays, respectively. It also demonstrated notable reducing capacity in Fe3+ reduction (0.702 μg/mL), CUPRAC (1.444 μg/mL), and FRAP (0.964 μg/mL) assays. Significant inhibitory ability was observed against hCA I (1.12 μg/mL), hCA II (1.33 μg/mL), AChE (1.44 μg/mL), BChE (1.52 μg/mL), α-glucosidase (2.04 μg/mL), and α-amylase (2.11 μg/mL). Docking analyses indicated that major constituents, particularly quinic acid, could interact with key catalytic residues through hydrogen bonding and electrostatic interactions. Conclusions: Royal jelly possesses a rich polyphenolic profile accompanied by substantial antioxidant and multi-target enzyme-inhibitory abilities. These findings provide biochemical and molecular evidence supporting the potential of royal jelly as a functional food and nutraceutical ingredient and highlight its value as a source of bioactive compounds for further pharmacological investigation.